These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23989916)

  • 1. Characteristics of undertreatment in COPD in the general population.
    Ingebrigtsen TS; Marott JL; Vestbo J; Hallas J; Nordestgaard BG; Dahl M; Lange P
    Chest; 2013 Dec; 144(6):1811-1818. PubMed ID: 23989916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.
    Ingebrigtsen TS; Marott JL; Lange P; Hallas J; Nordestgaard BG; Vestbo J
    Respir Med; 2015 Dec; 109(12):1562-8. PubMed ID: 26560643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory medication use in primary care among COPD subjects in four Latin American countries.
    Jardim JR; Stirbulov R; Moreno D; Zabert G; Lopez-Varela MV; Montes de Oca M
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):458-465. PubMed ID: 28284262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.
    Postma DS; Anzueto AR; Jenkins C; Make BJ; Similowski T; Östlund O; Eriksson GS; Calverley PM
    Respir Med; 2013 Dec; 107(12):1939-47. PubMed ID: 23953956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A three years longitudinal follow-up study of pulmonary function changes in patients with chronic obstructive pulmonary disease].
    Wang J; Zhou XM; Yang X; Zhao ST; Ma QL; Wang CZ
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):302-6. PubMed ID: 27030620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey to determine the efficacy and safety of guideline-based pharmacological therapy for chronic obstructive pulmonary disease patients not previously receiving maintenance treatment.
    Setoguchi Y; Izumi S; Nakamura H; Hanada S; Marumo K; Kurosaki A; Akata S
    Expert Opin Pharmacother; 2015; 16(15):2271-81. PubMed ID: 26290277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium.
    Anzueto A; Tashkin D; Menjoge S; Kesten S
    Pulm Pharmacol Ther; 2005; 18(2):75-81. PubMed ID: 15649848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A year in the life of German patients with COPD: the DACCORD observational study.
    Buhl R; Criée CP; Kardos P; Vogelmeier C; Lossi N; Mailänder C; Worth H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1639-46. PubMed ID: 27499620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.